week
firstgener
viral
diagnost
test
becam
avail
hong
kong
sarscov
diagnosi
carri
three
laboratori
one
depart
microbiolog
queen
mari
hospit
qmh
result
specimen
investig
qmh
laboratori
april
may
subsequ
followup
specimen
includ
analysi
clinic
specimen
use
viral
rna
detect
includ
nasopharyng
aspir
throat
nose
swab
saliva
sputum
endotrach
aspir
fece
urin
nasopharyng
aspir
collect
mucu
trap
residu
secret
cathet
suck
trap
aspir
ml
viru
transport
medium
swab
collect
ml
viru
transport
medium
contain
vancomycin
final
concentr
amikacin
nystatin
uml
urin
fece
collect
specimen
contain
submit
directli
laboratori
without
addit
transport
medium
case
definit
previous
describ
patient
categor
clinic
basi
clinic
sar
suspect
sar
sar
attend
clinician
depend
respons
antimicrobi
therapi
bacteri
pathogen
eg
tazocin
g
intraven
hd
azithromycin
mgday
clinic
radiolog
evolut
ill
histori
contact
patient
sar
altern
diagnosi
fulli
explain
clinic
find
fecal
throat
swab
serum
specimen
control
obtain
comparison
fecal
specimen
patient
diarrhea
anonym
test
sarscov
rna
throat
swab
specimen
collect
inform
consent
patient
attend
primari
care
facil
nonrespiratori
diseas
test
sarscov
rna
blood
donor
sera
left
screen
bloodborn
virus
test
anonym
antibodi
sarscov
rna
extract
perform
use
qiaamp
viral
rna
kit
reagent
qiagen
hilden
germani
accord
manufactur
instruct
rtpcr
primer
condit
describ
sinc
primer
gave
occasion
falseposit
reaction
stool
specimen
pcrposit
stool
specimen
retest
lightcycl
pcr
roch
diagnost
gmbh
mannheim
germani
confirm
use
two
set
primer
melt
curv
analysi
use
provid
addit
confirm
reaction
specif
plasmid
vector
pcriitopo
invitrogen
san
diego
ca
contain
rnadepend
rna
polymeraseencod
sequenc
viru
use
refer
standard
seri
five
dilut
correspond
x
x
copi
per
reaction
refer
standard
run
parallel
test
sampl
specimen
resuspend
viru
transport
medium
use
infect
fetal
rhesu
monkey
kidney
cell
monolay
cultur
tube
approxim
g
fece
sampl
resuspend
ml
viru
transport
medium
centrifug
supernat
spread
onto
cell
respiratori
sampl
alreadi
dilut
viru
transport
medium
spread
onto
cell
monolay
incub
h
cell
fed
ml
minimum
essenti
medium
fetal
calf
serum
gibcobrl
grand
island
ny
incub
cultur
examin
cytopath
effect
cpe
day
day
end
incub
period
cpe
appear
cell
spot
teflonco
slide
fix
icecold
aceton
stain
sarscov
antigen
use
convalescentphas
human
serum
identif
isol
confirm
rtpcr
coronaviru
immunoglobulin
g
serolog
test
perform
indirect
immunofluoresc
batch
vero
cell
smear
prepar
fix
icecold
aceton
minut
cell
adjust
sarscov
infect
judg
immunofluoresc
stain
control
posit
human
convalescentphas
serum
fix
smear
store
use
serum
sampl
screen
dilut
infect
uninfect
control
cell
minut
incub
cell
wash
twice
phosphatebuff
salin
pb
minut
goat
antihuman
fluorescein
isothiocyan
conjug
inova
diagnost
inc
san
diego
ca
ad
cell
incub
minut
cell
wash
describ
examin
immunofluoresc
microscop
serum
sampl
posit
screen
dilut
titrat
serial
twofold
dilut
parallel
respect
acutephas
serum
specimen
patient
posit
control
serum
test
batch
cell
viru
isol
prepar
cell
smear
serolog
test
done
biosafeti
level
bsl
laboratori
routin
handl
clinic
specimen
rna
extract
serolog
test
immunofluoresc
done
laboratori
basic
laboratori
practic
reinforc
educ
staff
close
supervis
work
practic
serum
specimen
antibodi
test
heat
inactiv
minut
test
sensit
specif
rtpcr
real
time
lightcycl
assay
report
total
respiratori
fecal
urin
specimen
serum
sampl
test
sarscov
rna
antibodi
respect
patient
initi
clinic
suspicion
sar
consid
laboratori
result
retrospect
correl
clinic
diagnos
patient
clinic
patient
consid
clinic
sar
suspect
sar
sar
third
group
includ
patient
hospit
febril
respiratori
ill
mani
radiolog
chang
sar
initi
consid
differenti
diagnosi
overal
patient
one
specimen
test
sarscov
rna
rtpcr
acut
convalescentphas
serum
sampl
avail
serolog
analysi
convalescentphas
serum
taken
least
day
onset
ill
specimen
rtpcr
avail
similar
proport
patient
clinic
categori
pair
sera
frequent
avail
patient
clinic
categor
sar
patient
sar
categori
tabl
patient
clinic
diagnos
sar
patient
evid
sarscov
rna
clinic
specimen
contrast
clinic
diagnos
sar
categori
rtpcr
evid
sarscov
infect
tabl
assess
extent
circul
sarscov
gener
popul
fecal
specimen
submit
investig
diarrheal
ill
patient
thought
sar
nose
throat
swab
patient
visit
gener
practic
nonrespiratori
ill
test
viral
rna
rtpcr
none
control
throat
swab
specimen
control
stool
specimen
evid
detect
sarscov
rna
patient
clinic
sar
pair
sera
avail
rise
antibodi
titer
sarscov
none
control
seroconvers
sarscov
two
patient
clinic
diagnos
sar
categori
seroconvert
tabl
convalescentphas
sera
patient
group
fail
show
seroposit
patient
data
shown
neither
two
patient
histori
contact
patient
sar
howev
one
left
midzon
consolid
confirm
highresolut
comput
tomographi
scan
discharg
diagnosi
pneumonia
unknown
caus
mild
febril
ill
unknown
caus
without
radiolog
evid
consolid
none
blood
donor
serum
sampl
collect
hong
kong
march
addit
serum
sampl
collect
may
evid
antibodi
sar
profil
sarscov
rna
detect
patient
serolog
confirm
sarscov
infect
analyz
figur
viral
rna
detect
respiratori
tract
proport
patient
within
first
day
ill
detect
stool
urin
specimen
day
ill
respect
proport
respiratori
stool
specimen
posit
viral
rna
progress
increas
peak
approxim
day
ill
nasopharyng
aspir
throat
nose
swab
product
specimen
first
day
diseas
stool
sampl
use
day
ill
although
rate
detect
clinic
specimen
gradual
decreas
day
onward
viral
rna
could
still
detect
day
ill
sampl
nasopharynx
fece
urin
small
proport
patient
figur
smaller
number
saliva
endotrach
aspir
sputum
specimen
avail
test
tabl
sinc
confirm
laboratori
diagnosi
sar
within
first
day
ill
greatest
clinic
need
studi
diagnost
yield
differ
specimen
patient
serolog
confirm
sarscov
infect
period
tabl
sputum
appear
good
clinic
specimen
earli
stage
diseas
although
number
specimen
test
small
nasopharyng
aspir
throat
nose
swab
appear
compar
sensit
respect
stool
specimen
less
use
specimen
first
day
ill
sensit
saliva
endotrach
aspir
altern
specimen
tabl
could
assess
use
lack
specimen
collect
earli
stage
ill
patient
whose
first
specimen
test
neg
second
specimen
type
collect
within
first
day
ill
three
posit
addit
diagnost
yield
second
specimen
approxim
data
shown
viru
isol
retrospect
store
clinic
specimen
rtpcr
posit
viral
rna
tabl
viru
readili
isol
respiratori
tract
stool
specimen
furthermor
viru
isol
success
first
week
ill
gener
neg
day
ill
even
though
viru
detect
specimen
rtpcr
april
firstgener
diagnost
test
sarscov
becam
avail
clinician
care
patient
sar
consid
differenti
diagnosi
normal
new
laboratori
diagnost
test
extens
evalu
valid
introduc
routin
clinic
practic
howev
case
sar
new
poorli
understood
diseas
firstgener
test
result
provid
clinician
understand
test
valid
result
interpret
caution
continu
improv
sensit
rtpcr
method
make
analysi
sensit
firstgener
diagnost
method
less
relev
howev
result
provid
use
inform
best
specimen
detect
viru
differ
stage
ill
tissu
tropism
viru
durat
viru
excret
cultur
sarscov
prepar
virusinfect
cell
smear
viru
isol
carri
condit
routin
clinic
specimen
process
clinic
virolog
laboratori
condit
enhanc
reinforc
educ
safeti
good
laboratori
practic
given
specimen
per
day
process
rtpcr
detect
serolog
test
peak
period
workload
could
manag
laboratori
none
laboratori
staff
becam
ill
sar
symptom
indic
clinic
specimen
serolog
test
rtpcr
process
safe
level
condit
associ
sarscov
clinic
syndrom
sar
illustr
detect
rate
viral
rna
clinic
specimen
patient
sar
nonsar
group
control
viral
rna
detect
firstgener
rtpcr
test
less
sensit
serolog
test
diagnos
sar
correspondingli
patient
clinic
diagnos
sar
none
pair
sera
unrel
control
seroconvert
sarscov
howev
patient
design
sar
categori
pair
sera
avail
also
seroconvert
pair
sera
avail
patient
sar
group
time
intens
pressur
clinic
frontlin
staff
littl
incent
obtain
convalescentphas
sera
patient
believ
sar
patient
may
repres
bias
sampl
larger
group
nonsar
patient
content
support
fact
convalescentphas
sera
subsequ
obtain
group
sar
patient
fail
show
addit
antibodi
sar
even
patient
sar
categori
febril
respiratori
often
pneumon
ill
one
two
patient
sar
categori
evid
seroconvers
undiagnos
pneumon
ill
undiagnos
febril
ill
without
radiolog
consolid
lung
overal
clinic
diagnosi
sar
close
correl
detect
viral
rna
rtpcr
seroconvers
support
etiolog
associ
sarscov
sar
none
blood
donor
sera
collect
hong
kong
height
sar
outbreak
evid
antibodi
viru
find
suggest
spread
sarscov
infect
gener
commun
minim
infect
associ
cluster
hospit
outbreak
rtpcr
detect
rate
sarscov
respiratori
stool
urin
specimen
patient
seroconvers
sarscov
show
viral
shed
progress
increas
onset
ill
approxim
day
onset
sinc
firstgener
rtpcr
test
rel
low
sensit
result
reflect
increas
viral
load
differ
clinic
site
ill
wherea
data
crosssect
previou
studi
viral
load
nasopharyng
aspir
follow
longitudin
nasopharyng
specimen
collect
day
ill
onset
result
studi
also
indic
viral
load
peak
day
ill
profil
progress
increas
viral
load
unusu
respiratori
viral
infect
infect
eg
respiratori
syncyti
viru
influenza
peak
viral
titer
respiratori
secret
soon
onset
clinic
ill
viral
titer
laboratori
diagnost
yield
decreas
progress
crescendo
pattern
sarscov
detect
rate
viral
load
clinic
specimen
number
implic
pattern
explain
poor
sensit
firstgener
diagnost
test
first
day
ill
emphas
challeng
make
laboratori
diagnosi
earli
diseas
result
may
also
suggest
fundament
differ
efficaci
innat
immun
respons
control
sarscov
infect
contrast
exampl
influenza
infect
innat
immun
mechan
earliest
host
defens
control
viral
replic
case
mani
respiratori
virus
within
first
day
ill
even
specif
adapt
immun
respons
activ
respons
appear
occur
sar
viral
load
respiratori
tract
begin
fall
antibodi
respons
appear
ie
approxim
day
onset
ill
find
may
suggest
sarscov
abl
evad
host
innat
respons
requir
adapt
immun
respons
bring
infect
control
final
peak
viral
load
week
ill
would
predict
viru
like
transmit
later
cours
ill
result
inde
accord
epidemiolog
observ
regard
observ
viral
load
frequent
use
steroid
therapi
hospit
confound
factor
may
contribut
increas
viru
load
later
ill
rel
viru
detect
rate
differ
specimen
ill
suggest
respiratori
specimen
nasopharyng
aspir
throat
swab
use
first
day
ill
fecal
sampl
better
later
ill
urin
sampl
hand
use
stage
ill
product
cough
common
earli
stage
ill
patient
produc
sputum
specimen
provid
high
diagnost
yield
thu
nasopharyng
aspir
throat
swab
sputum
avail
best
specimen
first
day
ill
detect
viru
fecal
urin
sampl
addit
respiratori
tract
suggest
sar
restrict
respiratori
tract
find
diarrhea
unrel
antimicrobi
drug
use
number
patient
support
evid
diseas
pure
respiratori
one
number
anim
coronavirus
eg
mous
hepat
viru
felin
coronaviru
tropism
multipl
organ
viral
shed
detect
rtpcr
respiratori
gastrointestin
urinari
tract
mani
week
onset
ill
reflect
continu
viru
replic
site
howev
sarscov
readili
cultur
site
week
ill
viral
rna
detect
rtpcr
week
ill
unlik
repres
persist
viral
rna
absenc
ongo
viral
replic
appar
dissoci
viru
isol
rtpcr
may
reflect
mucos
antibodi
neutral
viru
render
less
infecti
observ
also
accord
appar
absenc
transmiss
infect
week
ill
fact
viru
isol
done
retrospect
may
affect
overal
isol
rate
howev
sarscov
appear
rel
stabl
freez
thaw
stabl
mani
week
clinic
specimen
frozen
kh
chan
jsm
peiri
unpub
data
event
bia
would
expect
uniform
earli
late
diseas
summari
sar
close
associ
epidemiolog
novel
sarscov
unusu
profil
viral
shed
respiratori
tract
may
explain
observ
transmiss
pattern
diseas
includ
predilect
affect
healthcar
worker
